Aspirin therapy found to be ineffective in nearly half of patients

06/28/2004 | Reuters Health

A small study involving patients hospitalized after a stroke or transient ischemic attack found nearly half were resistant to aspirin anti-clotting therapy. Results of the study, reported at the World Stroke Congress, showed 47% of the stroke or TIA patients evidenced aspirin resistance, which is defined as a clotting time of 171 seconds or less.

View Full Article in:

Reuters Health

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA